Navigation Links
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Date:2/2/2011

INDIANAPOLIS and PRINCETON, N.J., Feb. 2, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that they have stopped enrollment in one of their two global Phase III studies evaluating necitumumab, an investigational anti-cancer agent, as a first-line treatment for advanced non-small cell lung cancer (NSCLC).

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)

The randomized, multi-center, open-label Phase III trial, named INSPIRE, is evaluating the addition of necitumumab, a fully-human IgG1 monoclonal antibody, to a combination of  ALIMTA® (pemetrexed for injection) and cisplatin compared to a regimen of ALIMTA and cisplatin, as a first-line treatment for patients with advanced nonsquamous NSCLC. No new safety issues were seen in the control arm with Alimta and cisplatin.

The decision to stop enrollment followed an independent Data Monitoring Committee (DMC) recommendation that no new or recently enrolled patients continue treatment in the trial because of safety concerns related to thromboembolism (blood clots) in the experimental arm of the study. The DMC also noted that patients who have already received two or more cycles of necitumumab appear to have a lower ongoing risk for these safety concerns. These patients may choose to remain on the trial, after being informed of the additional potential risks. Investigators will continue to assess patients after two cycles to determine if there is a potential benefit from treatment.  

As noted earlier, necitumumab continues to be studied in a Phase III trial named SQUIRE. This study is evaluating necitumumab as a potential treatment for a different type of lung cancer called squamous non-small cell lung cancer in combination with GEM
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
2. Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
3. Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb
4. Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
5. Top Bristol-Myers Squibb Executive Joins Patton Boggs
6. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
7. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
8. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
9. Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
10. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
11. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... CHAPEL HILL, N.C. , May 17, 2013 ... on how organizations communicate internally. Faced with a ... adjust their strategies and tactics for communicating with ... the effectiveness of all the strategies, tactics and ... In a new study, Best ...
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology ... Sony SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting ... which will be held at the San ... Diego, California , from May 20 - 22.  ... second analytical system, incorporating commercial audio-visual technologies into new ...
(Date:5/17/2013)... May 17, 2013  TechAtlas Group has announced ... competitive landscape map for the Chronic Kidney Disease ... international companies with drugs and devices currently on ... its sequelae. (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ... , hypertension - renal denervation , diabetic ...
Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2
... , , BENLYSTA ... TRIALS , , ... (HGS) and GlaxoSmithKline (GSK) announced positive results from a year-long clinical ... the lupus patients who were treated with BENLYSTA had improvement in ...
... , , , ... Genome Sciences, Inc. (Nasdaq: HGSI ) and GlaxoSmithKline ... the primary endpoint in BLISS-52, the first of two pivotal ... erythematosus (SLE). In the placebo-controlled BLISS-52 study, the results ...
Cached Medicine Technology:First Potential Lupus-Specific Treatment in Sight 2First Potential Lupus-Specific Treatment in Sight 3Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 2Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 3Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 4Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 5Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 6Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 7Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 8Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 9Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus 10
(Date:5/19/2013)... The muscles in the human body ... one of the biggest and most significant nervous systems ... peripheral system comprises of peripheral nerves that reside outside ... ensure that the limbs and hands, as well as ... get damaged due to trauma or physical injury, their ...
(Date:5/19/2013)... 2013 6Webs.com is the leader in ... who are considering an alarm system can do a ... leading security system providers online at 6Webs.com. Just recently ... DIY home security system companies, 6Webs.com currently is ... of home security companies before ranking the home security ...
(Date:5/19/2013)... New York (PRWEB) May 19, 2013 ... a Case Management Conference was recently convened for hundreds ... federal multidistrict litigation now underway in U.S. District Court, ... on the Court’s website on May 14th, the Conference ... It was also reported during the Conference that Defendants ...
(Date:5/19/2013)... The Fat Loss Code program developed by Shawn Stevenson covers ... get in shape, and gain a healthy life regardless of ... a natural fat loss system that provides people with effective ... loss diet program claimed that The Fat Loss Code is ... fat off long-term. After Shawn Stevenson launched this new body ...
(Date:5/19/2013)... 2013 Exciting new Skin Brushes are ... a great practice known through the ages but is ... dry body brushing, has so many benefits for our ... Beauty®. "We love that circulation and lymphatic systems get ... the skin, is supported through Skin Brushing." , Why ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2
... Tomorrow, millions of Americans will wear red to ... times as many women die from heart disease as breast cancer ... of primary care doctors still don,t know that heart attacks kill ... urging women to continue wearing red once a week, to help ...
... using the latest three-dimensional imaging system in their ... practitioners. , Cone Beam Computed Tomography (CBCT), which ... medical CT scan, is now available in high-street ... patients, jaws and teeth. , However, CBCT carries ...
... diagnosed in Germany each year could be avoided. If precancerous ... are detected and removed at an early stage, there is ... , Therefore, statutory health insurances in Germany offer a ... persons from the age of 50. This test can detect ...
... can be just one click away and there,s a growing ... dating. From its dubious beginnings four centuries ago the personal ... finding that perfect partner. , Dr Harry Cocks, a ... Nottingham, has just published a book telling the story of ...
... Perfect Plate announces its revolutionary new weight loss tool to ... Perfect Plate is an affordable and safe weight loss tool with ... gimmick, it,s a lifestyle change that you can hold in the ... any food you like and as long as the lid closes ...
... INDIANAPOLIS, Feb. 5 WellPoint, Inc. commends President,Barack ... Children,s Health,Insurance Program (SCHIP). This signature will provide ... children, regardless of their parents,income, receive proper health ... is a great example of successful partnerships between ...
Cached Medicine News:Health News:'Go Red for Women' Gets Stronger by the Week 2Health News:Colorectal cancer: Immunological tests for more accurate detection of cancer precursors 2Health News:Classified -- the lonely heart's long road to respectability 2Health News:WellPoint Applauds President Obama for Signing SCHIP Reauthorization 2
... LASIK surgery and other types of ... corneal interface and/or stromal bed. Flattened ... flap and helps elevate the flap ... Two 25G (.50mm) parallel tips. Angled ...
... product designed for LASIK surgery and ... to irrigate the corneal interface and/or ... insertion under the flap and helps ... provide multi-directional irrigation. 25G x 7/8in ...
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 23G x 7/8 in (.60 x 22mm). .3mm end port. Olive shape tip is 2mm long x 1mm w...
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)...
Medicine Products: